Pacla Medical (PACLA)

Last close As at 04/11/2024

0.00 (0.00%)

Market capitalisation

Latest Insights

Healthcare | edison tv

Pacla Medical – executive interview

Healthcare | QuickView

Pacla Medical — Backhug: Treating spinal joint stiffness

Financials

Pacla Medical is a private health care technology firm that has developed Backhug, a robotic physiotherapy device for treating pain. Pacla operates a scalable subscription model where customers typically pay £99/month for a 12-month contract (there is also a purchase option), potentially generating high levels of SaaS-type recurring revenue. The addressable market to reduce back pain is estimated at about 197 million people globally and worth $76bn in annual revenues. Pacla’s sales for the last 12 months were £21k; it has already sold 25 units and has a waiting list for 300. The planned £5m capital raise would allow expansion into the key US market and facilitate targeted growth to c 5k units over the next 18 months, with Pacla expecting FY24 sales to reach £14.1m.

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free